In Vitro Metabolism of the Emerging Contaminant 6Ppd-Quinone in Human and Rat Liver Microsomes: Kinetics, Pathways, and Mechanism.

Yuan-Yuan Zhang,Jun-Wei Huang,Yue-Hong Liu,Jin-Na Zhang,Zheng Huang,You-Sheng Liu,Jian-Liang Zhao,Guang-Guo Ying
DOI: https://doi.org/10.1016/j.envpol.2024.123514
IF: 8.9
2024-01-01
Environmental Pollution
Abstract:N-(1,3-dimethylbutyl)-N '-phenyl-p-phenylenediamine-quinone (6PPD-Q) is an ozonation product of the rubber antioxidant N-(1,3-dimethylbutyl)-N '-phenyl-p-phenylenediamine (6PPD). 6PPD-Q has recently been detected in various environmental media, which may enter the human body via inhalation and skin contact pathways. However, the human metabolism of 6PPD-Q has remained unknown. This study investigated the in vitro Cytochrome P450-mediated metabolism of 6PPD-Q in human and rat liver microsomes (HLMs and RLMs). 6PPD-Q was significantly metabolized at lower concentrations but slowed at high concentrations. The intrinsic clearance (CLint) of 6PPD-Q was 21.10 and 18.58 mu L min(-1) mg(-1) protein of HLMs and RLMs, respectively, suggesting low metabolic ability compared with other reported pollutants. Seven metabolites and one intermediate were identified, and metabolites were predicted immunotoxic or mutagenic toxicity. Mono- and di-oxygenation reactions were the main phase I in vitro metabolic pathways. Enzyme inhibition experiments and molecular docking techniques were further used to reveal the metabolic mechanism. CYP1A2, 3A4, and 2C19, especially CYP1A2, play critical roles in 6PPD-Q metabolism in HLMs, whereas 6PPD-Q is extensively metabolized in RLMs. Our study is the first to demonstrate the in vitro metabolic profile of 6PPD-Q in HLMs and RLMs. The results will significantly contribute to future human health management targeting the emerging pollutant 6PPD-Q.
What problem does this paper attempt to address?